MLKL and hepatocellular carcinoma: A recent study shows that mixed lineage kinase domain-like pseudokinase (MLKL) deficiency in hepatocellular carcinoma cells restricts ER Mg2+ release and mitochondrial Mg2+ uptake, leading to ER dysfunction, mitochondrial oxidative stress, and, ultimately, metabolic-stress-induced parthanatos (121).